Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Rogers, Leland; Zhang, Peixin; Vogelbaum, Michael A; Perry, Arie; Ashby, Lynn S; Modi, Jignesh M; Alleman, Anthony M; Galvin, James; Brachman, David; Jenrette, Joseph M; De Groot, John; Bovi, Joseph A; Werner-Wasik, Maria; Knisely, Jonathan P S; Mehta, Minesh P

Rogers, Leland; Zhang, Peixin; Vogelbaum, Michael A; Perry, Arie; Ashby, Lynn S; Modi, Jignesh M; Alleman, Anthony M; Galvin, James; Brachman, David; Jenrette, Joseph M; De Groot, John; Bovi, Joseph A; Werner-Wasik, Maria; Knisely, Jonathan P S; Mehta, Minesh P.

Afiliación

Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Zhang P; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
Vogelbaum MA; Cleveland Clinic Foundation, Cleveland, Ohio.
Perry A; Department of Pathology, University of California, San Francisco, California.
Ashby LS; Department of Radiation Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Modi JM; MidState Medical Center, Hartford HealthCare, Meriden, Connecticut.
Alleman AM; Department of Radiological Science, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Galvin J; Imaging and Radiation Oncology Core QA Group, Thomas Jefferson University, Philadelphia, Pennsylvania.
Brachman D; Department of Radiation Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Jenrette JM; Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.
De Groot J; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Bovi JA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Werner-Wasik M; Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.
Knisely JPS; Department of Radiation Medicine, Hofstra North Shore, Manhasset, New York; and.
Mehta MP; Miami Cancer Institute Executive Office, Miami, Florida.

J Neurosurg ; 129(1): 35-47, 2018 07.

Article en En | MEDLINE | ID: mdl-28984517

Asunto(s)

Neoplasias Meníngeas/mortalidad; Neoplasias Meníngeas/radioterapia; Meningioma/mortalidad; Meningioma/radioterapia; Femenino; Humanos; Masculino; Persona de Mediana Edad; Supervivencia sin Progresión; Estudios Prospectivos; Medición de Riesgo; Tasa de Supervivencia; Resultado del Tratamiento

Palabras clave

3DCRT = 3D conformal RT; AE = adverse event; CGE = cobalt gray equivalent; CNED = continual no evidence of disease; CTV = clinical tumor volume; EBRT = external beam RT; EORTC = European Organisation for Research and Treatment of Cancer; GTR = gross-total resection; GTV = gross tumor volume; IMRT = intensity-modulated RT; MMSE = Mini-Mental State Examination; OAR = organ at risk; OS = overall survival; PD = progressive disease; PFS = progression-free survival; PRV = planning risk volume; PTV = planning target volume; PTVPRV = overlap between the PTV and the particular PRV of concern; RT = radiation therapy; RTOG = Radiation Therapy Oncology Group; SD = stable disease; SRS = stereotactic radiosurgery; STR = subtotal resection; WHO = World Health Organization; WHO Grade II (atypical); meningioma; oncology; radiotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Neurosurg Año: 2018 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google